In Depth

Personalised medicine demands diversity in clinical trials

Equity requires us to recognise and celebrate our differences, especially when it comes to health. To exemplify the need for diversity in clinical trials, Daniel Cook discusses what the underlying ra…

Comment And Analysis

A Million to One: Bridging the biomarker chasm from discovery to the clinic

With so much research being published on biomarkers, yet so few companion diagnostic devices being cleared by the FDA, Rafael Rosengarten discusses why it is so hard to develop a biomarker to the poi…


Evolving prostate cancer research with FFPE samples

Dr. Nallasivam Palanisamy of the Henry Ford Health System and Michigan State University and Dr. Han Wei of Beckman Coulter Life Sciences, who have been collaborating, together with their respective t…